PHASE-I TRIAL OF SEMUSTINE PLUS WEEKLY FLUOROURACIL AND HIGH-DOSE LEUCOVORIN CALCIUM IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

被引：2
|
作者：
ABBRUZZESE, JL [1 ]
WEEKS, A [1 ]
RABER, MN [1 ]
GRAVEL, D [1 ]
DUBROW, RA [1 ]
LEVIN, B [1 ]
GREM, J [1 ]
CHUN, HG [1 ]
机构：
[1] NCI, DIV CANC TREATMENT, BETHESDA, MD 20205 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 23期
关键词：
D O I：
10.1093/jnci/81.23.1840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1840 / 1842
页数：3
相关论文
共 50 条
  • [21] A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
    Lin, Chia-Chi
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    Lu, Yen-Shen
    Hsu, Chiun
    Yeh, Kun-Huei
    Wu, Chen-Yao
    Huang, Chiun-Sheng
    Yang, Chih-Hsin
    ANTICANCER RESEARCH, 2007, 27 (1B) : 641 - 645
  • [22] TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CARCINOMAS WITH FLUOROURACIL ALONE, HIGH-DOSE LEUCOVORIN PLUS FLUOROURACIL, OR SEQUENTIAL METHOTREXATE, FLUOROURACIL, AND LEUCOVORIN - A RANDOMIZED TRIAL OF THE NORTHERN-CALIFORNIA-ONCOLOGY-GROUP
    VALONE, FH
    FRIEDMAN, MA
    WITTLINGER, PS
    DRAKES, T
    EISENBERG, PD
    MALEC, M
    HANNIGAN, JF
    BROWN, BW
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1427 - 1436
  • [23] Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer
    Yamada, Y
    Ohtsu, A
    Boku, N
    Miyata, Y
    Shimada, Y
    Doi, T
    Muro, K
    Muto, M
    Hamaguchi, T
    Mera, K
    Yano, T
    Tanigawara, Y
    Shirao, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (04) : 218 - 223
  • [24] Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience
    Wang, WS
    Chen, PM
    Chiou, TJ
    Liu, JH
    Lin, JK
    Lin, TC
    Chen, WS
    Jiang, JK
    Yen, CC
    Fan, FS
    Hsieh, RK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (01) : 16 - 19
  • [25] A Phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer
    Haas, NB
    Schilder, RJ
    Nash, S
    Weiner, LM
    Catalano, RC
    Ozols, RF
    ODwyer, PJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 229 - 233
  • [26] A PHASE-I TRIAL OF WEEKLY LOMUSTINE IN PATIENTS WITH ADVANCED CANCER
    KOLLER, CA
    GORSKI, CC
    BENJAMIN, RS
    LEGHA, SS
    PAPADOPOULOS, NE
    PLAGER, C
    CANCER, 1994, 73 (01) : 236 - 239
  • [27] Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil
    Nozue, M
    Isaka, N
    Maruyama, T
    Kawamoto, T
    Seino, K
    Tanagichi, H
    Fukao, K
    ONCOLOGY REPORTS, 2002, 9 (01) : 93 - 96
  • [28] Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion:: Results of a randomized trial in patients with advanced colorectal cancer
    Köhne, CH
    Schöffski, P
    Wilke, H
    Käufer, C
    Andreesen, R
    Ohl, U
    Klaasen, U
    Westerhausen, M
    Hiddemann, W
    Schott, G
    Harstick, A
    Bade, J
    Horster, A
    Schubert, U
    Hecker, H
    Dörken, B
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 418 - 426
  • [29] PHASE-II TRIAL OF 5-FLUOROURACIL, HIGH-DOSE LEUCOVORIN CALCIUM, AND DIPYRIDAMOLE IN ADVANCED PROSTATE-CANCER
    SINGH, D
    DOROSHOW, JH
    LEONG, L
    MARGOLIN, K
    AKMAN, S
    RASCHKO, J
    SOMLO, G
    MORGAN, R
    HARRISON, J
    CHO, J
    AHN, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (02) : 117 - 120
  • [30] PHASE-I STUDY OF HIGH-DOSE 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN WITH LOW-DOSE PHOSPHONACETYL-L-ASPARTIC ACID IN PATIENTS WITH ADVANCED MALIGNANCIES
    ARDALAN, B
    STRIDHAR, K
    REDDY, R
    BENEDETTO, P
    RICHMAN, S
    WALDMAN, S
    MORRELL, L
    FEUN, L
    SAVARAJ, N
    LIVINGSTONE, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (03): : 511 - 514
12345